文献速递前列腺增生与排尿功能障碍

Urolume尿道支架置入后尿道成形术:国际多中心经验

Urethroplasty After Urethral Urolume Stent: An International Multicenter Experience.
PubMed 文献 · Urology · 2018-05-08

这项回顾性国际多中心研究纳入63例Urolume尿道支架置入后狭窄复发行尿道重建的患者,评估尿道成形术的结局及影响因素。中位随访59.7±63.4个月,成功率为81%,并发症发生率12.7%(均为Clavien-Dindo≤2级)。

要点

  • Urolume支架后尿道成形术成功率达81%,并发症低且轻微。
  • 逐根取出支架联合口腔黏膜补片覆盖是首选且效果最佳的技术。
  • 术后1、3、5年无病生存率分别为88.1%、79.5%、76.7%。

核心结论

  • Urolume尿道支架置入后行尿道成形术是可行的重建选择,成功率高且并发症可接受。
  • 尿道保留、逐根取出支架联合口腔黏膜补片 augmentation 可获得显著更优的结局。

研究设计与样本

  • 回顾性国际多中心研究,纳入63例Urolume尿道支架置入后狭窄复发并接受尿道重建的患者。
  • 分析支架及狭窄长度、支架置入至尿道成形术时间、年龄、支架取出方式、尿道成形术式、并发症及术前术后排尿参数。

主要发现

  • 61例在尿道成形术时取出支架;平均随访59.7±63.4个月,成功率为81%。
  • 10例(15.9%)行扩张或内尿道切开术,5例(7.9%)行再次尿道成形术。
  • 总IPSS、生活质量、最大尿流率及残余尿量均显著改善(P<.0001)。
  • 并发症8例(12.7%),均为Clavien-Dindo≤2级。
  • 重建后1、3、5年无病生存率分别为88.1%、79.5%、76.7%。

关键数值与推荐

  • 成功结局定义为排尿正常且无需任何术后辅助操作。
  • 重建技术包括切除端端吻合14例(22.2%)、背侧覆盖口腔黏膜补片9例(14.3%)、腹侧覆盖口腔黏膜补片6例(9.5%)、背侧覆盖口腔黏膜补片9例(14.3%)、腹侧覆盖加背侧嵌入补片3例(4.8%)、augmented吻合5例(7.9%)、带蒂皮瓣尿道成形术6例(9.5%)、二期手术4例(6.4%)、会阴尿道造口7例(11.1%)。
  • 逐根取出支架联合覆盖口腔黏膜补片是最常用方法,且显著优于其他技术(P=.018)。

临床怎么用

  • 对于Urolume支架置入后狭窄复发的患者,尿道成形术是可行的重建选项。
  • 推荐采用尿道保留、逐根取出支架联合口腔黏膜补片 augmentation 的技术以提高成功率。

局限性

  • 回顾性研究设计可能存在选择偏倚和信息偏倚。
  • 样本量有限(63例),随访时间变异较大(标准差63.4个月)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the outcomes and factors affecting success of urethroplasty in patients with stricture recurrence after Urolume urethral stent. MATERIAL AND METHODS: This is a retrospective international multicenter study on patients treated with urethral reconstruction after Urolume stent. Stricture and stent length, time between urethral stent insertion and urethroplasty, age, mode of stent retrieval, type of urethroplasty, complications and baseline, and posturethroplasty voiding parameters were analyzed. Successful outcome was defined as standard voiding, without need of any postoperative adjunctive procedure. RESULTS: Sixty-three patients were included. Stent was removed at urethroplasty in 61 patients. Reconstruction technique was excision and primary anastomosis in 14 (22.2%), dorsal onlay buccal mucosa graft (BMG) in 9 (14.3%), ventral onlay BMG in 6 (9.5%), dorsolateral onlay BMG in 9 (14.3%), ventral onlay plus dorsal inlay BMG in 3 (4.8%), augmented anastomosis in 5 (7.9%), pedicled flap urethroplasty in 6 (9.5%), 2-stage procedure in 4 (6.4%), and perineal urethrostomy in 7(11.1%). Success rate was 81% at a mean 59.7 ± 63.4 months. Dilatation or internal urethrotomy was performed in 10 (15.9%) and redo-urethroplasty in 5 (7.9%). Total International Prostate Symptom Score, quality of life, urine maximum flow, and postvoid residual significantly improved (P <.0001). Complications occurred in 8 (12.7%), all Clavien-Dindo ≤2. Disease-free survival rate after reconstruction was 88.1%, 79.5%, and 76.7% at 1, 3, and 5 years, respectively. Explant of individual strands followed by onlay BMG is the most common approach and was significantly advantageous over the other techniques (P = .018). CONCLUSION: Urethroplasty in patients with Urolume urethral stents is a viable option of reconstruction with a high success rate and very acceptable complication rate. Numerous techniques are viable; however, urethral preservation, tine-by-tine stent extraction, and use of BMG augmentation produced significantly better outcomes.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Angulo JC, Kulkarni S, Pankaj J, et al. Urethroplasty After Urethral Urolume Stent: An International Multicenter Experience. Urology. 2018. PMID: 29751026. doi:10.1016/j.urology.2018.04.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。